A mathematical framework for separating the direct and bystander components of cellular radiation response

Abstract A mathematical model for fractional tumor cell survival was developed incorporating components of cell killing due to direct radiation interactions and bystander signals resulting from non-local dose deposition. Material and methods. Three possible mechanisms for signal production were tested by fitting predictions to available experimental results for tumor cells (non-small cell lung cancer NCI-H460 and melanoma MM576) exposed to gradient x-ray fields. The parameter fitting allowed estimation of the contribution of bystander signaling to cell death (20–50% for all models). Separation of the two components of cell killing allowed determination of the α and β parameters of the linear-quadratic model both with and without the presence of bystander signaling. Results and discussion. For both cell lines, cell death from bystander signaling and direct radiation interactions were comparable. For NCI-H460 cells, the values for α and β were 0.18 Gy−1 and 0.10 Gy−2 respectively when direct and bystander effects were combined, and 0.053 Gy−1 and 0.061 Gy−2 respectively when the signaling component was removed. For MM576, the corresponding respective values were 0.09 Gy−1 and 0.011 Gy−2 for the combined response, and 0.014 Gy−1 and 0.002 Gy−2 for the isolated direct radiation response. The bystander component in cell death was found to be significant and should not be ignored. Further experimental evidence is required to determine how these results translate to the in vivo situation where tumor control probability (TCP) models that currently assume cellular independence may need to be revised.

[1]  N. Suchowerska,et al.  A review of in vitro experimental evidence for the effect of spatial and temporal modulation of radiation dose on response , 2010, Acta oncologica.

[2]  T. Delaney,et al.  Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .

[3]  Michael C. Joiner,et al.  Basic Clinical Radiobiology , 2009 .

[4]  N. Suchowerska,et al.  The radiobiological effect of intra-fraction dose-rate modulation in intensity modulated radiation therapy (IMRT) , 2008, Physics in medicine and biology.

[5]  Igor Shuryak,et al.  Biophysical Models of Radiation Bystander Effects: 1. Spatial Effects in Three-Dimensional Tissues , 2007, Radiation research.

[6]  N Suchowerska,et al.  Cellular response to modulated radiation fields , 2007, Physics in medicine and biology.

[7]  A Ottolenghi,et al.  Modelling radiation-induced bystander effect and cellular communication. , 2006, Radiation protection dosimetry.

[8]  W. Tomé,et al.  Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. , 2006, International journal of radiation oncology, biology, physics.

[9]  C-K Chris Wang,et al.  A nanodosimetry-based linear-quadratic model of cell survival for mixed-LET radiations , 2006, Physics in medicine and biology.

[10]  W. Tomé,et al.  Does a local bystander effect necessitate a revision of TCP models that are based on observed clinical data? , 2006, Acta oncologica.

[11]  R. Dale,et al.  The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. , 2005, The British journal of radiology.

[12]  N Suchowerska,et al.  In vitro response of tumour cells to non-uniform irradiation , 2005, Physics in medicine and biology.

[13]  M. Little,et al.  A model for radiation-induced bystander effects, with allowance for spatial position and the effects of cell turnover. , 2005, Journal of theoretical biology.

[14]  Kevin M Prise,et al.  Targeted cytoplasmic irradiation induces bystander responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Nikjoo,et al.  A theoretical approach to the role and critical issues associated with bystander effect in risk estimation , 2004, Human & experimental toxicology.

[16]  K M Prise,et al.  A review of the bystander effect and its implications for low-dose exposure. , 2003, Radiation protection dosimetry.

[17]  H. Nikjoo,et al.  Biophysical model of the radiation-induced bystander effect , 2003, International journal of radiation biology.

[18]  Applied Radiobiology and Bioeffect Planning , 2001 .

[19]  D. Brenner,et al.  The Bystander Effect in Radiation Oncogenesis: I. Transformation in C3H 10T½ Cells In Vitro can be Initiated in the Unirradiated Neighbors of Irradiated Cells , 2001, Radiation research.

[20]  D. J. Brenner,et al.  The Bystander Effect in Radiation Oncogenesis: II. A Quantitative Model , 2001, Radiation research.

[21]  M A Ebert,et al.  Viability of the EUD and TCP concepts as reliable dose indicators. , 2000, Physics in medicine and biology.

[22]  R C Miller,et al.  The oncogenic transforming potential of the passage of single alpha particles through mammalian cell nuclei. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. D. Chapman,et al.  The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles. , 1997, Radiation research.

[24]  C. Mothersill,et al.  Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. , 1997, International journal of radiation biology.

[25]  P. Hoban,et al.  Some characteristics of tumour control probability for heterogeneous tumours. , 1996, Physics in medicine and biology.

[26]  A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumours. , 1996, Acta oncologica.

[27]  P. Stavrev,et al.  Comments on the article 'A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density'. , 1995, Physics in medicine and biology.

[28]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[29]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[30]  R. Bristow,et al.  Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. , 1990, International journal of radiation oncology, biology, physics.

[31]  A. Brahme,et al.  Optimal dose distribution for eradication of heterogeneous tumours. , 1987, Acta oncologica.

[32]  W. Press,et al.  Numerical recipes in C. The art of scientific computing , 1987 .

[33]  J J Fischer,et al.  Theoretical considerations in the optimisation of dose distribution in radiation therapy. , 1969, The British journal of radiology.